Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor. (2018)
Attributed to:
Understanding synthetic lethality of ATR inhibitors with DDR dysregulation common in ovarian cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cam4.1724
PubMed Identifier: 30109783
Publication URI: http://europepmc.org/abstract/MED/30109783
Type: Journal Article/Review
Volume: 7
Parent Publication: Cancer medicine
Issue: 9
ISSN: 2045-7634